Although both hepatic-secreted proteins are positively associated with hepatic steatosis, insulin resistance, and diabetes, the fetuin-B mechanism of action is different from AHSG, which acts as an inhibitor of insulin receptors [35, 40]. Here, FETUB is linked to Insulin resistance.